Is a complete ETR/ZEG research report available?

No complete published report is available for etr/ZEG (ETR/ZEG) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

etr/ZEG stock profile: metrics, valuation and analysis

Market cap	212.2B
Revenue (ttm)	53.7B
Net income (ttm)	9.1B
EPS (ttm)	€5.85
P/E (trailing)	23.2x
P/E (forward)	14.7x
Dividend	€2.76 (1.72%)
Volume	14,221
Beta	0.20

All ETR/ZEG indicators

Market & fundamental data

Available fields

251

Groups with data

Currency

USD

Showing 251 of 251 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	DE
Employees	96,100
Employees Change	1,800%
Employees Change Percent	1.91
Enterprise value	EUR 236.2B
Exchange	Deutsche Börse Xetra
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	GB0009895292
Last refreshed	2026-09-11
Market cap	EUR 212.2B
Price	EUR 161
Price currency	EUR
Rev Per Employee	558,935.07x
Sector	Healthcare
Sector PE	37.8
Sector PE Fwd	14.25
Sic	2834
Symbol	etr/ZEG
Website	https://www.astrazeneca.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.31%
EV Earnings	25.84x
EV/EBIT	18.42x
EV/EBITDA	13.27x
EV/FCF	25.3x
EV/Sales	4.39x
FCF yield	4.4%
Forward P/E	14.69x
P/B ratio	4.81x
P/E ratio	23.2x
P/S ratio	3.95x
PE Ratio10 Y	84.65x
PE Ratio3 Y	30.99x
PE Ratio5 Y	130.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.86%
EBITDA Margin	32.43%
FCF margin	17.67%
Gross margin	81.69%
Gross Profit	EUR 43.9B
Gross Profit Growth	7.69%
Gross Profit Growth Q	7.25%
Gross Profit Growth3 Y	9.19%
Gross Profit Growth5 Y	17.24%
Net Income	EUR 9.1B
Net Income Growth	25.93%
Net Income Growth Q	2.33%
Net Income Growth Qo Q	-18.6%
Net Income Growth Quarters	11%
Net Income Growth Years	4%
Net Income Growth3 Y	19.23%
Net Income Growth5 Y	22.6%
Pretax Margin	20.51%
Profit Margin	17.02%
Profit Per Employee	EUR 95,144
Profitable Quarters	EUR 18
Profitable Years	36
ROA	8.02
Roa5y	5.95
ROCE	17.37
ROE	21.96
Roe5y	13.03
ROIC	16.05
Roic5y	13.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	15.11%
Cagr15y	13.9%
Cagr1y	25.23%
Cagr20y	10.27%
Cagr3y	13.87%
Cagr5y	16.83%
Div CAGR10	1.04%
Div CAGR3	0.95%
Div CAGR5	3.14%
EPS Growth	25.84
EPS Growth Q	2.55
EPS Growth Qo Q	-18.27
EPS Growth Quarters	11
EPS Growth Years	4
EPS Growth3 Y	19.13
EPS Growth5 Y	18.4
FCF Growth	-4.55%
FCF Growth Q	-22.92%
FCF Growth Qo Q	-25.25%
FCF Growth3 Y	5.66%
FCF Growth5 Y	14.81%
OCF Growth	2.32%
OCF Growth Q	-15.39%
OCF Growth Qo Q	-14.71%
OCF Growth10 Y	14.02%
OCF Growth3 Y	10.41%
OCF Growth5 Y	16.27%
Revenue Growth	8.61x
Revenue Growth Q	6.41x
Revenue Growth Qo Q	0.63x
Revenue Growth Quarters	13x
Revenue Growth Years	7x
Revenue Growth3 Y	11.32x
Revenue Growth5 Y	15.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.54
Assets	EUR 101.4B
Cash	EUR 4.3B
Current Assets	EUR 24.1B
Current Liabilities	EUR 27.2B
Debt	EUR 28.3B
Debt EBITDA	EUR 1.59
Debt Equity	EUR 0.64
Debt FCF	EUR 3.03
Equity	EUR 44.1B
Interest Coverage	10.4
Liabilities	EUR 57.3B
Long Term Assets	EUR 77.3B
Long Term Liabilities	EUR 30.1B
Net Cash	EUR -24B
Net Cash By Market Cap	EUR -11.3
Net Debt EBITDA	EUR 1.38
Net Debt Equity	EUR 0.54
Net Debt FCF	EUR 2.57
Tangible Book Value	EUR -7.5B
Tangible Book Value Per Share	EUR -4.86
WACC	5.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.89
Inventory Turnover	1.68
Net Working Capital	EUR -1.9B
Quick ratio	0.66
Working Capital	EUR -3.1B
Working Capital Turnover	EUR -13.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.03%
Dividend Growth	-5.26%
Dividend Growth Years	4%
Dividend per share	EUR 2.76
Dividend Years	26
Dividend Yield	1.72%
Ex Div Date	2026-08-06
Last Dividend	EUR 0.93
Payout Frequency	Semi-Annual
Payout Ratio	45.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	308.57%
1Y total return	25.21%
200-day SMA	138.6
3Y total return	47.67%
50-day SMA	158.1
50-day SMA vs 200-day SMA	50over200
5Y total return	117.62%
All Time High	166.3
All Time High Change	-3.37%
All Time High Date	2026-01-15
All Time Low	22.38
All Time Low Change	618.05%
All Time Low Date	2008-03-18
ATR	3.36
Beta	0.21
Ch YTD	1.81
High	161.2
High52	166.3
High52 Date	2026-01-15
High52ch	-3.37%
Low	157.9
Low52	111
Low52 Date	2025-04-09
Low52ch	44.78%
Ma50ch	1.62%
Price vs 200-day SMA	15.96%
RSI	53.92
RSI Monthly	62.68
RSI Weekly	63.27
Sharpe ratio	0.52x
Sharpe Ratio3y	0.34x
Sharpe Ratio5y	0.6x
Sortino ratio	1
Sortino Ratio3y	0.72
Sortino Ratio5y	1.11
Total Return	1.75%
Tr YTD	3.58
Tr15y	604.42%
Tr1m	4.57%
Tr1w	5.07%
Tr3m	15.01%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,542,969,962%
Net Borrowing	-1,626,211,808
Shares Insiders	0.04%
Shares Institutions	74.06%
Shares Qo Q	-0.06%
Shares Yo Y	-0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 9B
Adjusted OCF	11,671,250,200
Average Volume	10,875.65x
Bv Per Share	28.38
CAPEX	EUR -2.7B
Ch10y	195.5
Ch15y	346.4
Ch1m	2.78
Ch1w	3.28
Ch1y	20.47
Ch20y	308.4
Ch3m	13.05
Ch3y	36.19
Ch5y	90.76
Ch6m	25.55
Change	0.59%
Change From Open	1.13
Close	159.8
Days Gap	-0.53
Depreciation Amortization	4,534,960,365
Dollar Volume	2,285,314.7
Earnings Date	2026-10-30
EBIT	EUR 12.8B
EBITDA	EUR 17.4B
EPS	EUR 5.85
F Score	7
FCF	EUR 9.3B
FCF EV Yield	3.95x
Financing CF	-6,722,304,000
Fiscal Year End	December
Founded	1,992
Goodwill	18,244,063,721
Graham Number	72.13439
Graham Upside	-55.11
Income Tax	EUR 1.9B
Investing CF	-7,134,570,300
Is Primary Listing	0
Last Earnings Date	2026-07-27
Last Report Date	2026-06-30
Lynch Fair Value	EUR 157
Lynch Upside	-2.6
Ma150	143.4
Ma150ch	12.04%
Ma20	159.6
Ma20ch	0.72%
Net CF	-1,880,144,400
Next Earnings Date	2026-10-30
Open	158.9
P FCF Ratio	22.72
P FCF Ratio SBC	23.53
P OCF Ratio	17.69
P OCF Ratio SBC	18.18
Payment Date	2026-09-08
Position In Range	84.85
Ppne	14,039,858,300
Price Date	2026-02-05
Price EBITDA	EUR 12.18
Relative Volume	1.31x
Revenue	53,713,659,800x
SBC By Revenue	0.6x
Share Based Comp	320,359,800
Tax By Revenue	3.48x
Tax Rate	16.95%
Tr20y	607.01%
Tr6m	28.62%
Volume	14,221
Z Score	3.57

ETR/ZEG (ETR/ZEG)

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/ZEG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/ZEG indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on ETR/ZEG

Frequently asked questions